These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3468268)
21. HIV IgM antibodies in risk groups who are seronegative on ELISA testing. Bedarida G; Cambiè G; D'Agostino F; Ronsivalle MG; Berto E; Grisi ME Lancet; 1986 Sep; 2(8506):570-1. PubMed ID: 2875298 [No Abstract] [Full Text] [Related]
22. Lymphoproliferative responses to human immunodeficiency virus antigen in asymptomatic intravenous drug abusers and in patients with lymphadenopathy or AIDS. Reddy MM; Englard A; Brown D; Buimovici-Klien E; Grieco MH J Infect Dis; 1987 Aug; 156(2):374-6. PubMed ID: 3474301 [No Abstract] [Full Text] [Related]
23. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy. De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880 [TBL] [Abstract][Full Text] [Related]
24. HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, Spain. Tor J; Muga R; Argelagues E; Rey-Joly C; Foz M; Ribas-Mundó M Arch Intern Med; 1986 Apr; 146(4):805. PubMed ID: 3008680 [No Abstract] [Full Text] [Related]
25. Human immunodeficiency virus antibody testing and counseling. Smiley ML; Meriwether R N C Med J; 1988 Jan; 49(1):5-7. PubMed ID: 3422356 [No Abstract] [Full Text] [Related]
26. [Prevalence of antibodies against human T-lymphotropic virus type III (HTLV-III) in parenteral drug addicts in the Barcelona area]. Muga R; Tor J; Argelagués E; Rey-Joly C; Foz M; Ribas-Mundó M Med Clin (Barc); 1986 Jan; 86(3):97-9. PubMed ID: 3457230 [No Abstract] [Full Text] [Related]
28. Increased prevalence of HTLV-III antibody among drug addicts from Italian province with US military base. Franceschi S; Tirelli U; Vaccher E; Serraino D; Sorio R; Carbone A; Monfardini S Lancet; 1986 Apr; 1(8484):804. PubMed ID: 2870299 [No Abstract] [Full Text] [Related]
29. [Prevalence of anti-HTLV III antibodies in detainees at the jail in Perugia]. Stagni G; Francisci D; Pegiati R; Baldelli F Boll Ist Sieroter Milan; 1987; 66(6):453-5. PubMed ID: 3453148 [TBL] [Abstract][Full Text] [Related]
30. [Immunity and drug addiction: immunologic situation in relation to the drug, HTLV-III infection and other associated infections]. Asensi V; Cartón JA; Fernández-León A; Cárcaba V; Navia-Osorio JM; Pérez R; Diéguez MA; Arribas JM Med Clin (Barc); 1986 Jan; 86(3):105-9. PubMed ID: 3007879 [No Abstract] [Full Text] [Related]
31. [HTLV-III infection in risk groups]. Esteban R; Buti M; Esteban JI; Hernández JM; Jardí R; Vila M; Tusell J; Guardia J Med Clin (Barc); 1986 Jan; 86(3):110-2. PubMed ID: 3007880 [No Abstract] [Full Text] [Related]
33. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid]. Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056 [No Abstract] [Full Text] [Related]
35. Prevalence of antibodies to human herpesvirus 6 in human immunodeficiency virus 1-seropositive and -negative intravenous drug addicts. Huemer HP; Larcher C; Wachter H; Dierich MP J Infect Dis; 1989 Sep; 160(3):549-50. PubMed ID: 2547885 [No Abstract] [Full Text] [Related]
36. Point-counterpoint: should premarital testing for HIV antibodies be made mandatory? Bradford LG; Bessinger CD J S C Med Assoc; 1987 Oct; 83(10):551-4. PubMed ID: 3479655 [No Abstract] [Full Text] [Related]
37. HTLV-I and HIV infection in drug addicts in Italy. Gradilone A; Zani M; Barillari G; Modesti M; Agliano AM; Maiorano G; Ortona L; Frati L; Manzari V Lancet; 1986 Sep; 2(8509):753-4. PubMed ID: 2876222 [No Abstract] [Full Text] [Related]
38. Immune status of drug abusers. Fuchs D; Hausen A; Reibnegger G; Schönitzer D; Unterweger B; Blecha HG; Hengster P; Rössler H; Schulz T; Werner ER Cancer Detect Prev Suppl; 1987; 1():535-41. PubMed ID: 3480066 [TBL] [Abstract][Full Text] [Related]
39. [Prevalence of antibodies against HTLV-III/LAV in subpopulations at risk of suffering the acquired immune deficiency syndrome]. Latorre X; Gatell JM; Pumarola T; Miró JM; Laborí C; Pifarré M; Vidal J; Jiménez de Anta MT; Soriano E; Pumarola A Med Clin (Barc); 1986 Jan; 86(3):113-4. PubMed ID: 3457226 [No Abstract] [Full Text] [Related]